Mid-term Combination Immunotherapy and its Effect on the Albumin-Bilirubin Score in Unresectable Hepatocellular Carcinoma. Kuwano A, Yada M, Tanaka K, Takahira J, et al. Anticancer Res 2025;45:1713-1721.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kuwano A, Yada M, Tanaka K, Takahira J, et al. Mid-term Combination Immunotherapy and its Effect on the Albumin-Bilirubin Score in Unresectable Hepatocellular Carcinoma. Anticancer Res 2025;45:1713-1721.
PMID: 40155043